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Access to and Control over Plant Genetic Resources 
for Food and Agriculture in South and Southern 
Africa: How Many Wrongs Before a Right? 
Debbie Collier* 
“[I]f agriculture is in trouble, Africa is in trouble.”1 
INTRODUCTION 
Agriculture is pivotal in the lives of many Africans.  In 
southern Africa, approximately eighty percent of the population 
is engaged in subsistence farming.2  Yet the agricultural output 
in many African countries is inadequate to meet local needs.3  
Food security in the region is negatively affected by a number 
of past and present, and internal and external, factors that 
include weather conditions, the colonial footprint, internal 
conflict, international trade obligations, market reform, and the 
impact of HIV/AIDS on community structure and livelihood.  
Many countries in the region are ultimately forced to rely upon 
                                                          
     ©      2006 Debbie Collier.      
      *      Lecturer in the Law Faculty, University of Cape Town, South Africa. 
B.A., L.L.B., Rhodes University; L.L.M., University of Cape Town.  
 1. Donald L. Sparks, Economic Trends in Africa South of the Sahara, in 
AFRICA SOUTH OF THE SAHARA 2003 11, 18 (Katharine Murison ed., 32d ed. 
2003) (quoting the World Bank) (internal quotations omitted). 
 2. The majority of the labor force in developing Africa is employed in 
agriculture, and typically agriculture can account for between thirty percent 
and eighty percent of GDP.  See id. at 18-19.  
 3. Although agricultural output unquestionably needs to be improved in 
southern Africa, the sad reality is that often domestic agricultural output is 
adequate to meet local needs.  The output, however, is bound up in commercial 
farming where much of the product is exported and, as many families lack the 
economic power to purchase food, particularly in rural areas, they remain 
hungry.  Consider for example the plight of thousands of seasonal fruit pickers 
who live in poverty in the prosperous Western Cape, South Africa.  See 
Andries du Toit, Hungry in the Valley of Plenty, MAIL & GUARDIAN, April 15 to 
21, 2005, at 28; see also Michael R. Taylor & Jerry Cayford, American Patent 
Policy, Biotechnology, and African Agriculture: The Case for Policy Change, 17 
HARV. J.L. & TECH. 321, 328-29 (2004). 
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food aid from international sources to feed their citizens.4 
Part of the solution to food insecurity proffered in recent 
years is the use of modern biotechnology5 in agriculture.6  This 
solution has received a mixed response in southern Africa,7 and 
in some countries the stance against genetically modified food 
is so strong that even pervasive droughts and endemic hunger 
were (almost) not enough to entice acceptance of genetically 
modified food aid from the United States in 2002.8  On the 
                                                          
 4. Heads of state and governments throughout the world have pledged 
their commitment to achieve food security and to eradicate hunger “with an 
immediate view to reducing the number of undernourished people to half their 
present level no later than 2015.”  Rome Declaration on World Food Security, 
in ROME DECLARATION ON WORLD FOOD SECURITY AND WORLD FOOD SUMMIT 
PLAN OF ACTION 1, 1 (1996); see also United Nations Millennium Declaration, 
G.A. Res. 55/2, ¶ 19, U.N. Doc. A/RES/55/2 (Sept. 18, 2000). 
 5. Article 3 of the Cartagena Protocol defines modern biotechnology as: 
[T]he application of: (a) In vitro nucleic acid techniques, including 
recombinant deoxyribonucleic acid (DNA) and direct injection of 
nucleic acid into cells or organelles, or (b) Fusion of cells beyond the 
taxonomic family, that overcome natural physiological reproductive or 
recombination barriers and that are not techniques used in 
traditional breeding and selection. 
SECRETARIAT OF THE CONVENTION ON BIOLOGICAL DIVERSITY, CARTAGENA 
PROTOCOL ON BIOSAFETY TO THE CONVENTION ON BIOLOGICAL DIVERSITY 4 
(2000) [hereinafter CARTAGENA PROTOCOL].  
 6. The use of biotechnology in agriculture and manufacturing is 
commonplace and established: biotechnology has been used for centuries to 
produce plant hybrids, foodstuffs and other products (such as fermentation in 
the making of beer and the processes used in making cheese and yogurt).  
Modern biotechnology, on the other hand, refers to new and controversial 
techniques which involve the transfer of genes between species (genetic 
engineering/genetic modification) in a manner and at a speed not previously 
possible.  See IQBAL PARKER ET AL., A NATIONAL BIOTECHNOLOGY STRATEGY 
FOR SOUTH AFRICA 1-3 (2001).  For example, the International Rice Research 
Institute (IRRI) is involved in research and development into drought-
resistant varieties of rice, and the Swaminathan Foundation in India is 
developing salt-tolerant rice varieties.  The University of Cape Town is 
conducting research into the development of maize which is resistant to the 
African endemic maize streak virus and which is tolerant to drought.  
Nevertheless, there is a counterargument that modern biotechnology in 
agriculture is not necessarily a useful tool in the fight against hunger and 
poverty, and that, inter alia, it can result in monocultures and soil erosion.  
See Cédric Cabanne, WIPO-UPOV Symposium on Intellectual Property Rights 
in Plant Biotechnology (Oct. 24, 2003), 
http://www.upov.int/en/documents/Symposium2003/. 
 7. See Briefing, Service Centre for Development Cooperation, The TRIPS 
Agreement: Patenting of Genetic Heritage and Food Security (Aug. 2003) 
(stating that it is unclear “whether the cultivation of genetically modified 
varieties is suited for the conditions of developing countries”). 
 8. Although Zambia stood by its rejection of the genetically modified 
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other hand, South Africa, although not plagued by food 
insecurity, but driven by industrial forces, has largely 
embraced genetically modified food crops.9  Either way, 
countries in Africa are moving forward in regulating modern 
biotechnology.10 
Resistance to the full-scale deployment of modern 
biotechnology in agriculture is twofold.  The predominant 
objection is based upon environmental, human, and animal 
health and safety concerns.11  These concerns are widely 
documented12 and have resulted in the drafting of numerous 
policy documents and legal instruments at national, regional, 
and international levels.  The second issue is that of control 
and ownership of plant genetic resources and private 
intellectual property rights in the products and processes of 
                                                          
crops, Lesotho, Malawi, and Mozambique eventually relented and accepted 
some 60,000 tons of U.S. genetically modified food aid.  See Taiwo A. Oriola, 
Consumer Dilemmas: The Right to Know, Safety, Ethics and Policy of 
Genetically Modified Food, SING. J. LEGAL STUD. 514, 514-15 & n.1 (2002).  
Zimbabwe, an exporter of unmodified crops, agreed to accept U.S. genetically 
modified maize on the condition that it would be allowed to mill the maize (at 
its own cost) such that farmers would subsequently be incapable of replanting 
it, and thus avoid the contamination of local crops.  See id. at 515 n.1. 
 9. By 2000, some 350,000 hectares had already been planted with 
genetically modified crops.  See ELFRIEDA PSCHORN-STRAUSS & RACHEL 
WYNBERG, THE SEEDS OF NEO-COLONIALISM: GENETIC ENGINEERING IN FOOD 
AND FARMING 1 (Mark Butler & David Hallowes eds., 2002).  More recently 
the South African government appears to be exercising some caution: In early 
2005, it was reported that the government rejected an application from Dow 
Agrosciences to run field trials of GM maize in South Africa.  See Bid to Test 
GM Maize in SA Gets Thumbs Down, CAPE TIMES, Jan. 31, 2005.  More 
recently, the South African government has placed a moratorium on 
genetically modified maize imports into South Africa while the Department of 
Trade and Industry studies the implications of such imports.  See Praise for 
GM Maize Ruling, NEWS24.COM, Oct. 28, 2005, 
http://www.news24.com/News24/South_Africa/News/0,,2-7-
1442_1825155,00.html. 
 10. The African Centre for Biosafety has documented many of the 
attempts to regulate biotechnology.  See African Biosafety Laws & Comments, 
http://www.biosafetyafrica.net/biosafety_laws_and_comments.htm (last visited 
Feb. 16, 2006). 
 11. See Oriola, supra note 8, at 545-55 (outlining environmental and 
public health concerns about potential adverse effects on biological diversity, 
genetic resources, and human health). 
 12. See, e.g., African Centre for Biosafety, http://www.biosafetyafrica.net/ 
(last visited Feb. 16, 2006); Biowatch South Africa, 
http://www.biowatch.org.za/ (last visited Feb. 16, 2006).  See generally Jeffrey 
M. Smith, SEEDS OF DECEPTION: EXPOSING INDUSTRY AND GOVERNMENT LIES 
ABOUT THE SAFETY OF THE GENETICALLY ENGINEERED FOODS YOU’RE EATING 
(2003). 
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modern agricultural biotechnology.13 
It is the latter, the control and ownership of plant genetic 
resources and the ownership of intellectual property rights in 
respect to plant genetic resources, which informs the thesis of 
this article.  It is common knowledge that the global 
intellectual property rights prescribed by the Agreement on 
Trade-Related Aspects of Intellectual Property Rights (TRIPS 
Agreement)14 conflict with the principles of the Convention on 
Biological Diversity (CBD),15 in particular as they relate to 
indigenous knowledge, and the control, access, and benefit-
sharing in plant genetic resources.16  Many African countries 
have signed both TRIPS and the CBD and are now attempting 
to reconcile the provisions in domestic law.  In doing so, the 
principles of the CBD and its associated instruments should 
not, and indeed need not, be compromised. 
The article will, in Part I, give a very broad, historical 
overview of agriculture on the African continent.  Part II will 
inform the reader of international and regional environmental 
law and intellectual property law instruments which aim to 
regulate the control and ownership of plant genetic resources 
and related biotechnological processes.  Part III will then 
consider domestic law (and the influence, in domestic law, of 
the international instruments discussed in Part II) in southern 
Africa, and particularly in South Africa.  To conclude, Part IV 
will review a case study of genetically modified cotton in South 
Africa which illustrates the current regulatory framework. 
                                                          
 13. See Andrew T. Mushita & Carol B. Thompson, Patenting Biodiversity? 
Rejecting WTO/TRIPS in Southern Africa, 2 GLOBAL ENVTL. POL. 65 (2002). 
 14. Agreement on Trade-Related Aspects of Intellectual Property Rights, 
Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade 
Organization, Annex IC, 1869 U.N.T.S. 299, 33 I.L.M. 1197 (1994) [hereinafter 
TRIPS Agreement]. 
 15. Convention on Biological Diversity, June 5, 1992, 31 I.L.M. 818 
[hereinafter Convention on Biological Diversity]. 
 16. See CATHERINE MONAGLE, CTR. FOR INT’L ENVTL. LAW & WORLD WIDE 
FUND FOR NATURE, BIODIVERSITY & INTELLECTUAL PROPERTY RIGHTS: 
REVIEWING INTELLECTUAL PROPERTY RIGHTS IN LIGHT OF THE OBJECTIVES OF 
THE CONVENTION ON BIOLOGICAL DIVERSITY (2001); Sunita K. Sreedharan, 
Reconciling TRIPs with the Convention on Biological Diversity – Indian 
Perspective, BUSINESS BRIEFING: PHARMAGENERICS 2004, at 39-41 (2004). 
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I. A BIRTHRIGHT OF ABUNDANCE AND A CULTURE OF 
SHARING 
Africa has an abundance of diversity: diversity of biological 
resources, as well as diversity of culture.  It is estimated that 
Africa, home to more than 2000 different ethnic groups,17 holds 
at least a quarter of the world’s biological diversity.18  Over 
centuries, African communities developed sophisticated 
agricultural practices, practices differing from those of other 
world regions.  As Devlin Kuyek explains: 
In sub-Saharan Africa, farming began in Ethiopia between the 4th 
and 6th millennia BC.  Not long after, migrating pastoral peoples took 
their agricultural practices to the rich, open lands of what is now 
Kenya and Tanzania.  In West Africa, the cultivation of millet began 
in Mauritania at around 1000 BC, while rice cultivation began in the 
Niger River Valley about a century later.  At the same time, 
communities in the West African forests started cultivating yam and 
oil palm.  Relative to other regions of the world, African farmers were 
slow to take up sedentary agriculture practices.  There were good 
reasons for this.  For one, they didn’t need to.  African communities 
generally had access to an abundance of land and could gather the 
plants they needed for food and medicine by foraging.  And, secondly, 
for large parts of Africa, environmental conditions made continuous, 
intensive agricultural production very difficult.19 
Access by local communities to the rich diversity of 
biological resources in Africa served as a shield against the 
recurring human and environmental calamities to which Africa 
is prone.  The relationship between African communities and 
Africa’s biological diversity was a mutually beneficial one: the 
innovative agricultural practices helped to conserve and 
sustain biodiversity.20  Indigenous communities classify,21 use, 
                                                          
 17. See MARIAM MAYET, SECURING SUSTAINABLE LIVELIHOODS: 
IMPERATIVES UNDERPINNING THE DEVELOPMENT OF AN APPROPRIATE REGIME 
TO PROTECT COMMUNITY RIGHTS TO BIODIVERSITY 2 (2000). 
 18. DEVLIN KUYEK, GENETIC RESOURCES ACTION INT’L, INTELLECTUAL 
PROPERTY RIGHTS IN AFRICAN AGRICULTURE: IMPLICATIONS FOR SMALL 
FARMERS 11 (2002).  South Africa alone is home to about ten percent of the 
world’s plant biodiversity, and is home to one of the six floral kingdoms of the 
world (the Cape Kingdom).  See Michael Kidd & Mariam Mayet, Access to 
Genetic Resources in South Africa, in AFRICAN PERSPECTIVES ON GENETIC 
RESOURCES: A HANDBOOK ON LAWS, POLICIES, AND INSTITUTIONS GOVERNING 
ACCESS AND BENEFIT-SHARING 231 (Kent Nnadozie et al. eds, 2003); Petro 
Terblanche, Case Study: San/CSIR Hoodia Benefit-Sharing Model, in FOOD 
SECURITY AND BIODIVERSITY: SHARING THE BENEFIT OF PLANT GENETIC 
RESOURCES 61 (2003), available at 
http://www.syngentafoundation.com/2004_review/World_Food_Day04.pdf. 
 19. KUYEK, supra note 18, at 2. 
 20. See MAYET, supra note 17.  Systems for conservation include “home 
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store, nurture, and cultivate a multitude of plant species.22  The 
knowledge acquired by African communities over the centuries 
is held collectively,23 but in recent years we have seen the 
increasing value of indigenous knowledge in the global trading 
market.24  The idea that knowledge is capable of private 
ownership is alien to and “culturally inappropriate”25 for 
indigenous communities in Africa which are characterized by 
their communal approach to the use and management of plant 
genetic resources.26 
Oral traditions and agricultural practices of African 
communities were directly, and indirectly, in the line of fire of 
the colonial powers after the “scramble for Africa” in the 
nineteenth century, which consolidated European interest and 
influence in Africa that had existed since the mid-fifteenth 
century European maritime explorations.27  Customary laws 
and traditions gave way to colonial law,28 and artificial 
                                                          
gardens, seed banks, and sacred groves.”  Id. 
 21. See Mushita & Thompson, supra note 13, at 74. 
 22. As explained by Kuyek: 
The Suazi of Swaziland, for instance, nurture and use about 200 plant 
species, and the Tembe Thonga of southern Africa regularly use 106 
species for their daily needs.  The Kpelle women in Liberia maintain 
over 100 varieties of rice [and] . . . [i]n southern Africa, women are 
reported to store seed of 10 ecotypes of sorghum and pearl millet at a 
given period in their homestead granaries. 
See KUYEK supra note 18, at 2. 
 23. Knowledge is generally acquired through membership of a community, 
and measures are in place for the reciprocal exchange of information among 
communities.  See Traditional African Concepts of Access, in AFRICAN 
PERSPECTIVES ON GENETIC RESOURCES, supra note 18, at 25, 27. 
 24. The financial rewards, of course, accrue to the corporation exploiting 
the resource.  It is estimated that “[a]bout 75 percent of active ingredients in 
pharmaceuticals come from plants in Southern countries.”  Mushita & 
Thompson, supra note 13, at 73.  Mushita and Thompson provide the following 
examples from Africa: the rosy periwinkle of Madagascar (exploited by Eli 
Lilly to develop drugs for testicular cancer and childhood leukemia), an 
Ethiopian crossbred barley (which previously saved the California crops from 
yellow dwarf virus), and a West African berry (which contains a plant protein 
2000 times sweeter than sugar).  See id. 
 25. MONAGLE, supra note 16, at 15.  
 26. See Traditional African Concepts of Access, supra note 23. 
 27. See Richard Brown, European Colonial Rule in Africa, in AFRICA 
SOUTH OF THE SAHARA, supra note 1, at 26, 26. 
 28. Legal systems in Africa are predominantly rooted in British common 
law, French civil law, or Roman-Dutch civil law, and at the time of 
colonization, colonial authorities were dismissive of indigenous legal systems.  
See generally id. at 26-28. 
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geographical boundaries created disharmony for local 
communities.  One such example is the Fulani in West Africa: 
[T]he Fulani in West Africa . . . traditionally keep their livestock in 
more arid areas during the wet season, where forage quality is 
relatively high.  In the dry season, when water becomes scarce in the 
north, they move their animals further south to more humid areas, 
where the livestock can graze the crop residues in harvested fields 
and the still-green grass in low-lying areas along streams and rivers.  
These herds are important sources of manure for arable farming and 
thus help to maintain a cycle of cooperation and interdependence 
between the pastoral and farming communities.  However, this 
particular system of resource use, amongst so many others, was 
disturbed by the drawing of national boundaries by colonial powers 
during the 19th and early 20th centuries.29 
In many instances, sweeping changes to land use patterns 
were implemented by the colonial authorities.  Communities 
were prohibited from cultivating certain crops without 
authorization or outside of designated territories and were cut 
off from their hunting and pastoral grounds, ultimately leading 
to a “reduction in the use and subsequent loss of local varieties, 
and the disruption of traditional farming systems that had 
evolved and adapted to the local environments over the 
centuries.”30 
African communities were dealt a further blow by the so-
called “Green Revolution”31 in the 1970s.  The Green 
Revolution was the global “industrialization” of agriculture: 
[The industrialization] started from the supply of biochemical 
technologies not market demand, contributed little to agricultural 
output and increased government debt. . . . [It] showed little respect 
for the knowledge of African farmers and their proven capacities to 
expand and adapt production to meet changing market conditions or 
for the varied ecologies of African countries.32 
                                                          
 29. See Traditional African Concepts of Access, supra note 23, at 29. 
 30. Id. 
 31. Advocates of genetically modified crops, in fact, liken the potential of 
genetic modification to the Green Revolution.  See STEPHEN GREENBERG, 
AFRICAN CENTRE FOR BIOSAFETY, GLOBAL AGRICULTURE AND GENETICALLY 
MODIFIED COTTON IN AFRICA 8-11 (2004). 
 32. Gavin Williams, Reforming Africa: Continuities and Changes, in 
AFRICA SOUTH OF THE SAHARA 2003, supra note 1, at 3, 5.  The Green 
Revolution, in a different context, had transformed the production of grain in 
Asia, although resulting in what is effectively a monoculture: 
In India, over 75 percent of total rice production uses less than 10 
percent of the 30,000 varieties of rice available.  In Bangladesh, with 
22 percent of the rice areas planted to modern varieties, 62 percent of 
those are from one maternal parent.  The current world food supply is 
highly vulnerable. 
Mushita & Thompson, supra note 13, at 75. 
COLLIER FINAL 6/7/2006  6:29:21 PM 
536 MINN. J.L. SCI. & TECH. [Vol. 7:2 
 
 
The technology transferred to the developing South during 
the Green Revolution consisted of high yielding seed varieties, 
irrigation systems, and chemical (fertilizer and insecticide) 
inputs from the developed North.  Although higher yields may 
well have been reached in some instances, the negative effect of 
the pesticide use is still being felt in Africa today,33 as is the 
social and economic impact of the Green Revolution, an ill-
suited and expensive exercise for small-scale farmers which 
often resulted in the displacement of farm-laborers and the 
marginalization of ill-resourced farmers. 
The formal freedom from colonial rule has not been 
successful in transforming the lives of many African people.  
The United Nations classifies forty-nine countries as least 
developed, thirty-four of which are found in Africa south of the 
Sahara.34  External and internal factors have held Africa’s 
potential at bay; disparities in income and inequality remain as 
access to power and the means to material wealth often entice 
those in power to move away from their stated agenda.35 
 
II. PLANT GENETIC RESOURCES IN THE GLOBAL AND 
REGIONAL CONTEXT 
In the past, plant genetic resources for food and agriculture 
were generally considered to be the “common heritage” of 
humankind.  Likewise, the technologies used to improve seeds 
and plants were generally in the public domain.36  Farmers and 
public research institutions that developed improved seeds 
would share the fruits of their labor, and seeds would be saved 
for exchange, sale, and cultivation.37  This is no longer so as 
biotechnology companies clamber for intellectual property 
protection for their products and processes.  That private 
                                                          
 33. See GREENBERG, supra note 31, at 10. 
 34. See Sparks, supra note 1, at 12. 
 35. See Williams, supra note 32, at 4-5. 
 36. A thread running through the diverse range of indigenous 
communities in Africa is that which relates to ownership of property: the 
concept of individual ownership of property is alien.  Hence, land and genetic 
(and biological) resources are communal in nature.  See Traditional African 
Concepts of Access, supra note 23, at 27-28. 
 37. It is estimated that ninety percent of food production in sub-Saharan 
Africa is based on seeds saved for cultivation.  See Service Centre for 
Development Cooperation, supra note 7; see also Mushita & Thompson, supra 
note 13, at 72.  
COLLIER FINAL 6/7/2006  6:29:21 PM 
2006] BIOTECHNOLOGY IN SOUTHERN AFRICA 537 
companies are winning in their fight to assert ownership over 
plant genetic resources is evident from the decision of the 
Canadian Supreme Court in Monsanto Canada, Inc. v. 
Schmeiser.38 
The recent availability of plant and biotechnology patents39 
in many countries has been accompanied by a rise in the 
commercial value of plants and seeds40 and a shift in the 
balance of biotechnological research and development from the 
public sector to private biotechnology entities.41  Private seed 
                                                          
 38. [2004] S.C.R. 902 (Can.).  In the Schmeiser case, Schmeiser had not 
purchased Roundup Ready canola nor had he obtained a license to plant 
Roundup Ready canola.  See id. at 902.  Tests, however, revealed that of 
Schmeiser’s 1998 canola crop, some ninety-five to ninety-eight percent was 
Roundup Ready canola.  See id. at 907.  Schmeiser suspected that the seed had 
either blown onto his property from neighboring fields or fallen from passing 
trucks.  See Bernard Shaw, Monsanto Wins Patent Case on Plant Genes, N.Y. 
TIMES, May 22, 2004, at C1. Nevertheless, Monsanto brought an action 
against Schmeiser for patent infringement.  See Schmeiser, [2004] S.C.R. at 
907.  The majority (5-to-4) in the Canadian Supreme Court upheld the patent 
on the basis that protection extended to the genes and modified cells that 
made up the plant (rather than the plant itself).  See id. at 909.  Moreover, it 
found that Schmeiser “used” the patented gene and cell through the saving 
and planting of the seed and the harvesting and selling of the plants 
containing the patented cells and genes, thus infringing the patent.  See id. at 
918.  The dissent, relying on the unpatentability of higher life forms and the 
availability of sui generis protection under the Plant Breeders’ Rights Act, 
would have allowed Schmeiser’s appeal.  See id. at 919-27. 
 39. Modern bio-techniques have received patent protection in the United 
States since the 1980s.  See Diamond v. Chakrabarty, 447 U.S. 303 (1980) 
(deciding by a marginal majority (5-to-4) that a strain of bacteria, genetically 
engineered to consume oil, could be patented); Ex parte Hibberd, 227 U.S.P.Q 
(BNA) 443 (Bd. of Pat. App. & Int. 1985) (expanding the scope of what the 
Patent and Trademark Office considered patentable biotechnologies from 
microorganisms to genetically modified plants); see also TRIPS Agreement, 
supra note 14, at art. 27 (requiring members of the WTO to make available 
patents for any inventions in all fields of technology and specifically requiring 
either patent or sui generis protection for plant varieties); Taylor & Cayford, 
supra note 3, at 345.  But see Harvard Coll. v. Canada (Comm’r of Patents), 
[2002] 4 S.C.R. 45 (Can.) (drawing the line at the patentability of “higher life 
forms” and holding that “oncomice” are not patentable).  Used for cancer 
research, an oncomouse is a genetically altered mouse produced by injecting a 
cancer-producing gene, the oncogene, into a fertilized mouse egg.  The 
oncomouse has been held patentable in much of Europe, Sweden, and the 
United States.  See generally Kirin-Amgen, Inc. v. Hoechst Marion Roussel 
Ltd, [2004] UKHL 46 (U.K.) (discussing the extent—and limits—of protection 
available to biotechnological product patents and, in particular, a “product-by-
process” claim). 
 40. See Service Centre for Development Cooperation, supra note 7 
(estimating that in 2003 the annual value of seed trade was thirty billion 
dollars). 
 41. See Taylor & Cayford, supra note 3, at 406 (stating that in the United 
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companies have clamped down on the rights to save, share, 
exchange, and sell seeds produced from cultivation,42 a sobering 
thought given the pressure43 developing countries are under to 
implement systems for the protection of intellectual property 
rights in terms of their obligations as World Trade 
Organization (WTO) members.44  Protection of higher life forms 
by way of patent is, in any event, fraught with conceptual 
difficulties: 
Because higher life forms can reproduce by themselves, the grant of a 
patent over a plant, seed or non-human animal covers not only the 
particular plant, seed or animal sold, but also all its progeny 
containing the patented invention for all generations until the expiry 
of the patent term. . . . [G]ranting the patent holder exclusive rights 
that extend not only to the particular organism embodying the 
invention but also to all subsequent progeny of that organism 
represents a significant increase in the scope of rights offered to 
patent holders.  It also represents a greater transfer of economic 
interests from the agricultural community to the biotechnology 
industry than exists in other fields of science.45 
Plant genetic resources for food and agriculture are the 
subject of numerous international instruments.  The CBD, 
reinforced by the International Treaty on Plant Genetic 
Resources for Food and Agriculture (ITPGR),46 vests control 
and access to genetic resources with national governments of 
the country of origin.47  On the other hand, the TRIPS 
                                                          
States “[o]f the 2,247 agricultural biotechnology patents that were issued from 
1975 to 1998, 525 were issued or assigned to universities or public 
institutions, 812 were issued or assigned to small firms or individuals, and 970 
were issued or assigned to corporations”).  
 42. See, e.g., Monsanto Canada, Inc. v. Schmeiser, [2004] S.C.R. 902 
(Can.); GM Company Sues Soy “Seed Saver” for Piracy, CAPE TIMES, Jan. 20, 
2005. 
 43. Although strictly speaking, patents are only enforceable in the issuing 
country, the United States is nonetheless able to put pressure on developing 
countries to adopt strong intellectual property regimes.  See generally Taylor 
& Cayford, supra note 3, at 365 (identifying at least three ways in which U.S. 
foreign policy exerts pressure: “implementation of the TRIPS Agreement, 
support for international harmonization and strengthening of patent law 
beyond what is required by TRIPS, and the use of trade agreements and trade 
sanctions to both protect U.S. intellectual property overseas and promote 
adoption of strong intellectual property regimes in other countries”).   
 44. See Mushita & Thompson, supra note 13. 
 45. CANADIAN BIOTECHNOLOGY ADVISORY COMM., PATENTING OF HIGHER 
LIFE FORMS AND RELATED ISSUES 12 (2002). 
 46. International Treaty on Plant Genetic Resources for Food and 
Agriculture, Nov. 3, 2001 [hereinafter ITPGR]. 
 47. See Convention on Biological Diversity, supra note 15. 
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Agreement, which harmonizes intellectual property rights, 
obliges some form of intellectual property protection for plant 
species, thereby creating a mechanism for privately-owned 
control of access to genetic resources.48  Although African 
countries are under pressure to implement, in domestic law, 
strong intellectual property rights akin to that of countries 
such as Canada and the United States, such rights, in many 
instances, appear to be inappropriate for Africa.  In addition, 
implementation of these rights is not required by international 
law, as will be explained below. 
Countries in southern Africa are members of the WTO and 
are also signatories to the CBD49 and its Cartagena Protocol on 
Biosafety.50  In addition, southern African countries are likely 
to sign the ITPGR.  South and southern Africa are therefore 
obliged to implement the provisions of the TRIPS Agreement as 
well as the principles in the CBD and the Cartagena Protocol.51  
A discussion of significant aspects of these major international 
and regional instruments follows. 
A. THE CBD AND ASSOCIATED INTERNATIONAL ENVIRONMENTAL 
LAW INSTRUMENTS 
The CBD came into effect in December 1993, and has as its 
objectives the conservation of biological diversity, and the 
sustainable use and fair and equitable sharing of the benefits 
arising out of the use of genetic resources.52  The CBD also 
recognizes “that economic and social development and poverty 
eradication are the first and overriding priorities of developing 
countries.”53 
On environmental and biosafety issues, the Cartagena 
Protocol on Biosafety provides an international regulatory 
framework for the “environmentally sound” application of 
                                                          
 48. See TRIPS Agreement, supra note 14. 
 49. The CBD was signed by 150 government leaders at the 1992 Rio Earth 
Summit.  See Convention on Biological Diversity, supra note 15. 
 50. See CARTAGENA PROTOCOL, supra note 5. 
 51. Mushita & Thompson, supra note 13 (considering the debate about 
intellectual property, particularly in agriculture, in southern Africa and the 
alternative approach to TRIPS—the African Model Law for the Protection of 
the Rights of Local Communities, Farmers and Breeders, and for the 
Regulation of Access to Biological Resources, encompassing the principles of 
the CBD and acknowledging and protecting farmer and local community 
rights). 
 52. See Convention on Biological Diversity, supra note 15, at art. 1. 
 53. Id. at pmbl. 
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biotechnology insofar as it prescribes levels of protection for the 
transfer, handling, and use of living modified organisms 
resulting from modern biotechnology.54  Moreover, a party may 
take into account socio-economic considerations, especially with 
regard to indigenous and local communities in reaching a 
decision on import under the protocol.55 
The CBD deals incisively with indigenous knowledge and 
requires that members, subject to national legislation: 
[R]espect, preserve and maintain knowledge, innovations and 
practices of indigenous and local communities embodying traditional 
lifestyles relevant for the conservation and sustainable use of 
biological diversity and promote their wider application with the 
approval and involvement of the holders of such knowledge, 
innovations and practices and encourage the equitable sharing of the 
benefits arising from the utilization of such knowledge, innovations 
and practice.56 
On the issue of control, the CBD provides that “States have 
. . . the sovereign right to exploit their own resources.”57  It is 
therefore up to individual states to regulate access to genetic 
resources.58  The CBD requires that access shall be subject to 
the “prior informed consent”59 of the country providing such 
resources and “shall be on mutually agreed terms.”60  Member 
states are required also to implement legislative, 
administrative, or policy measures that have “the aim of 
sharing in a fair and equitable way the results of research and 
development and the benefits arising from the commercial and 
other utilization of genetic resources with the Contracting 
Party providing such resources . . . upon mutually agreed 
terms.”61 
The flipside of access to plant genetic resources is access to 
and transfer of technology, particularly biotechnology.  The 
CBD provides that parties shall implement measures to 
provide access to and transfer of technology, particularly to 
developing countries that provide the plant genetic resources, 
including technology protected by patents and other 
                                                          
 54. See CARTAGENA PROTOCOL, supra note 5, at art. 1. 
 55. See id. at art. 26. 
 56. Convention on Biological Diversity, supra note 15, at art. 8(j). 
 57. Id. at art. 3. 
 58. See id. at art. 15(1). 
 59. Id. at art. 15(5). 
 60. Id. at art. 15(4). 
 61. See id. at art. 15(7). 
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intellectual property rights, subject to national legislation and 
international law.62 
Additional safeguards with respect to plant genetic 
resources specifically for food and agriculture are put in place 
by the ITPGR, which is closely linked to the CBD.63  The 
ITPGR seeks to regulate the conservation and sustainable use 
of plant genetic resources specifically for agriculture and food 
security, as well as the fair and equitable sharing of the 
benefits arising out of such use through a multilateral system 
of access and benefit-sharing.64  One of the crucial differences 
between the CBD and the ITPGR is the reliance, in the CBD, 
on individually negotiated bilateral agreements between 
parties,65 whereas the ITPGR establishes a multilateral 
(worldwide) system of exchange of plant genetic resources, even 
though the multilateral system only applies to listed crops. 66 
The ITPGR prohibits intellectual property rights over 
material obtained through the multilateral exchange, although 
it does not necessarily prohibit intellectual property protection 
over derivatives thereof.67  The international agreement 
requires member states to protect traditional knowledge with 
regard to plant genetic resources for food and agriculture, and 
to protect the rights of farmers to save, use, exchange, and sell 
farm-saved seed or propagating material, subject to national 
law.68  As mentioned above, insofar as access to and control 
over plant genetic resources are concerned, the agreement 
establishes a multilateral system of access and benefit-sharing 
covering the plant genetic resources for food and agriculture 
listed in Annex I to the agreement.69 
                                                          
 62. See Convention on Biological Diversity, supra note 15, at  pmbl. 
 63. See ITPGR, supra note 46, at art. 1.2. 
 64. See id. at art. 1.1.  The treaty lists numerous crops covered under the 
multilateral system, including oat, beet, chickpea, citrus, coconut, carrot, 
yams, strawberry, sunflower, barley, sweet potato, lentil, apple, cassava, 
banana, rice, beans pea, rye, potato, eggplant, sorghum, wheat, and maize.  
See id. at annex I. 
 65. See generally Convention on Biological Diversity, supra note 15. 
 66. See ITPGR, supra note 46, at pmbl. (explaining that “states may 
mutually benefit from the creation of an effective multilateral system for 
facilitated access to a negotiated selection of . . . resources”). 
 67. See id. at art. 12.3(d). 
 68. See id. at art. 9. 
 69. See id. at pt. IV (establishing the multilateral system of access and 
benefit-sharing). 
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B. THE TRIPS AGREEMENT 
The TRIPS Agreement was signed after the CBD entered 
into force and has a very different agenda.  TRIPS is motivated 
by international trade and economic law and aims to reduce 
impediments to international trade by requiring member states 
to provide adequate (universal) standards of trade-related 
intellectual property rights. 
The TRIPS Agreement is silent on indigenous knowledge, 
thereby leaving the door open to the abuse and 
misappropriation of traditional and indigenous knowledge,70 
unless its provisions are interpreted subject to the CBD and its 
associated agreements.  The problem is in foreign domestic law 
environments where countries are not signatories to the CBD, 
for example the United States or where patent offices do not 
actively evaluate patents.  A recent encouraging development 
in the European Patent Office saw the patent office, after a ten-
year challenge, uphold a decision to revoke a patent previously 
granted on a fungicidal product derived from the seeds of the 
Neem tree (Azadirachta indica), an indigenous tree in India, 
where the fungicidal properties of the tree had been public 
knowledge for centuries.71 
Insofar as plant genetic resources are concerned, Article 27 
of TRIPS obligates member states to provide for the patenting 
of any inventions, whether product or process, “in all fields of 
technology, provided they are new, involve an inventive step, 
and are capable of industrial application.”72  Although members 
may exclude from patentability plants, animals, and biological 
processes for the production of plants and animals, members 
must provide for the protection of plant varieties either by 
                                                          
 70. See generally MONAGLE, supra note 16, at 6.  Patents that have relied 
upon misappropriated indigenous knowledge include one granted to a Texas 
company over rice derived from traditional “Basmati rice” and a patent 
granted to the University of Wisconsin over a sweet substance derived from 
berries of a plant (Pentadiplandra brazzeana) from Gabon.  See id. 
 71. See Vir Singh, India Wins Seminal Case Against Patent Relating to 
Traditional Indian Knowledge, 69 PAT. TRADEMARK & COPYRIGHT J. 543 
(2005).  A patent that had been granted to the U.S. Department of Agriculture 
and the firm W.R. Grace for a method of extraction of oil from the Neem tree 
was revoked by the European Patent Office.  See Decision Revoking European 
Patent No. 0436257 (Feb. 13, 2000).  Nonetheless, at least one Neem tree 
patent remains in force in the United States.  See Margo A. Bagley, Patently 
Unconstitutional: The Geographical Limitation on Prior Art in a Small World, 
87 MINN. L. REV. 679, 680-82 (2003).   
 72. TRIPS Agreement, supra note 14, at art. 27(1) (emphasis added). 
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patent or by an effective sui generis system.73  A proliferation of 
patents appears to have come about in recent years,74 
frustrating access to information required, not only for 
commercial purposes, 75 but also for public interest reasons. 
One of the objectives of the TRIPS Agreement is the 
transfer and dissemination of technology.76  TRIPS anticipates 
that this objective will take place via the protection of 
intellectual property rights,77 although TRIPS does contain 
flexibilities for access to technology.78  But what TRIPS gives, 
TRIPS, or at least pressure from developed world trading 
partners,79 takes away: “Members may provide limited 
exceptions to the exclusive rights conferred by a patent, 
provided that such exceptions do not unreasonably conflict with 
a normal exploitation of the patent and do not unreasonably 
prejudice the legitimate interests of the patent owner.”80  
Members may “adopt measures necessary to protect public 
health and nutrition, and to promote the public interest in 
sectors of vital importance to their socio-economic and 
technological development, provided that such measures are 
                                                          
 73. See id. at art. 27(3)(b).  One such sui generis system is that which is 
protected under the International Union for the Protection of New Varieties of 
Plants (UPOV), based on the International Convention for the Protection of 
New Varieties of Plants, Dec. 1, 1961 (revised on Nov. 10, 1972, Oct. 23, 1978, 
and Mar. 19, 1991), available at 
http://www.upov.int/en/publications/conventions/1961/act1961.htm. 
 74. See Taylor & Cayford, supra note 3, at 406 (documenting databases on 
the issuance of patents that indicate “[t]he number of patents in . . . two 
classes [(Chemistry: Molecular Biology and Microbiology; Multicellular Living 
Organisms and Unmodified Parts Thereof and Related Processes)], closely 
related to plant biotechnology, has increased almost ninefold since 1981.”).  
According to Taylor and Cayford, “[i]n the same amount of time, overall utility 
patents per year slightly more than doubled.”  Id. 
 75. See id. at 349 (explaining that proliferation of patents results in a so-
called “patent thicket” around biotechnology, making access to technology 
difficult and expensive).  A patent thicket is “an overlapping set of patent 
rights requiring that those seeking to commercialize new technology obtain 
licenses from multiple patentees.”  Id. (quoting Carl Shapiro, Navigating the 
Patent Thicket: Cross-Licenses, Patent Pools, and Standard-Setting, in 
INNOVATION POL’Y & THE ECON. 119, 120 (Adam Jaffe et al. eds., 2001)). 
 76. See TRIPS Agreement, supra note 14, at art. 7.  
 77. See id. 
 78. See id. at arts. 8, 30-31, 40, 66.  
 79. See Taylor & Cayford, supra note 3, at 371 (asserting that “the United 
States uses its current leverage in trade negotiations, as well as trade 
sanctions and tariff benefits, to press observance of U.S. intellectual property 
rights in other countries and to seek adoption of patent regimes that go 
beyond what is required by TRIPS”).   
 80. TRIPS Agreement, supra note 14, at art. 30. 
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consistent with the provisions of . . . [the TRIPS] Agreement.”81  
Members may also provide for compulsory licenses in certain 
circumstances.82  These provisions arguably give TRIPS the 
flexibility to ensure a level of protection of indigenous or local 
communities and plant genetic resources comparable to the 
CBD.  The reality, however, is that this protection will not 
happen because of uneven trading powers, the limited 
resources available to Africa,83 and the fact that Africa appears 
to be easily seduced by technology. 
Article 27(3)(b) of the TRIPS Agreement, which requires 
intellectual property protection for plant varieties, provides for 
a review of the provision four years from the date of entry into 
force.  This scheduled review is now overdue.84  The 
submissions from the African Group in this regard can be 
summarized as follows: 
? There is a likelihood that the intellectual property 
protection required for plant varieties could 
negatively impact food security and exacerbate 
poverty.85 
? There is a lack of international mechanisms to deal 
with the misappropriation of genetic resources and 
traditional knowledge from developing countries.86 
? The patenting of life forms is abhorrent to African 
tradition and culture.87 
                                                          
 81. Id. at art. 8. 
 82. See id. at art. 31 (explaining that in some instances, members may 
allow for the use of  “the subject matter of a patent without the authorization 
of the right holder,” as long as certain provisions enumerated of the TRIPS 
Agreement are respected). 
 83. Many African countries do not have properly functioning intellectual 
property regimes, and are not in a position to sway the balance in favor of 
their communities’ best interests. 
 84. See Taking Forward the Review of Article 27.3(b) of the TRIPS 
Agreement – Joint Communication from the African Group, at 1, WTO Doc. 
IP/C/W/404 (June 26, 2003) [hereinafter Review of Article 27.3(b)] (noting that 
the review was to have been finalized by December 2002).   
 85. See id. at 3-4 (warning that although the “legitimate rights of 
commercial plant breeders should be protected, these should be balanced 
against the needs of farmers and local communities”). 
 86. See id. at 4-5 (cautioning against a “wait and see” attitude and urging 
the WTO to seek its own measures to protect against the misappropriation of 
genetic resources and traditional knowledge).  In light of its various concerns, 
the African Group has drafted a Decision on Traditional Knowledge containing 
its recommended measures, which it urges the WTO to adopt.  See id. at 6-9. 
 87. See id. at 2 (noting that these “patents are contrary to the moral and 
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The African Group implores its members not to derogate 
from the provisions of the CBD and the ITPGR, and it also 
encourages its members to explore ways to accommodate these 
environmental law instruments.88  To this extent, the African 
Group favors the adoption by African states of the African 
Model Legislation for the Protection of the Rights of Local 
Communities, Farmers and Breeders, and for the Regulation of 
Access to Biological Resources (African Model Law),89 
particularly in relation to a sui generis system for the 
protection of plant varieties.90   
Insofar as regulating indigenous knowledge and access to 
plant genetic resources is concerned, the African Group 
discusses the potential use of Article 29 of the TRIPS 
Agreement to modify rights and obligations created by the 
substantive provisions of TRIPS.91  Article 29, titled 
“Conditions on Patent Applicants,” provides for disclosure of 
information by the applicant.  The African Group suggests 
adding the following provision: “Members shall require an 
applicant for a patent to disclose the country and area of origin 
of any biological resources and traditional knowledge used or 
involved in the invention, and to provide confirmation of 
compliance with all access regulations in the country of 
origin.”92 
In addition to the international instruments dealt with 
above, there are a number of regional arrangements that could 
influence domestic law.  Regional arrangements arise out of 
bodies such as the African Union (AU) (formerly the 
Organization for African Unity (OAU)),93 as well as 
geographically defined organizations such as the Southern 
African Development Community (SADC)94 and the Economic 
                                                          
cultural norms of many societies in Members of the WTO . . . [and many 
Members] consider patents on life forms to be contrary to the fabric of their 
society and culture, and to be immoral”). 
 88. See id. 
 89. See Review of Article 27.3(b), supra note 84, at 2-3. 
 90. See id. at 3. 
 91. See id. at 6. 
 92. Id. at 6; cf. Patents Amendment Bill, 2005, Bill 17B-05 s. 2 (GA) 
(containing similar provisions).  
 93. See African Union, African Union in a Nutshell, 
http://www.africa-union.org/root/au/AboutAu/au_in_a_nutshell_en.htm (last 
visited Feb. 25, 2006). 
 94. Angola, Zambia, Malawi, Namibia, Botswana, Zimbabwe, 
Mozambique, South Africa, Lesotho, Swaziland, Democratic Republic of 
Congo, United Republic of Tanzania, and Mauritius are members of the 
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Community of West African States (ECOWAS).95  A number of 
English-speaking African countries, excluding South Africa, are 
also members of the African Regional Industrial Property 
Organization (ARIPO).96  A protocol adopted in 1982 allows the 
ARIPO office to grant patents and register designs on behalf of 
its member states.97  Its provisions, however, are flawed 
because the office lacks appropriate resources, and its staff 
lacks the requisite skills and expertise. 
The former OAU drafted two model laws—the African 
Model Law and the OAU Model Law on Safety in 
Biotechnology.  These model laws have the potential to have an 
impact on the domestic regulation of biotechnology, indigenous 
knowledge, control, access, and benefit-sharing in plant genetic 
resources.   
C. THE AFRICAN MODEL LAW 
The African Model Law provides Africa with “a legislative 
means to overcome the inequities of TRIPS,”98 and 
acknowledges that local communities possess certain rights 
over their biological resources and the technologies that have 
evolved over generations and are a priori rights of a collective 
nature that take precedence over rights based on private 
                                                          
SADC.  See Southern African Development Community, SADC Profile, 
http://www.sadc.int/english/about/profile/index.php (last visited Feb. 20, 2006). 
 95. ECOWAS was formed in 1975 and has fifteen countries on its current 
membership list:  Benin, Burkina Faso, Cape Verde, Côte d'Ivoire, Gambia, 
Ghana, Guinea, Guinea-Bissau, Liberia, Mali, Niger, Nigeria, Senegal, Sierra 
Leone, and Togo.  See Economic Community of West African States, 
http://www.ecowas.info (last visited Feb. 20, 2006). 
 96. There are currently fifteen members of ARIPO: Botswana, the 
Gambia, Ghana, Kenya, Lesotho, Malawi, Mozambique, Sierra Leone, 
Somalia, Sudan, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe.  See 
African Regional Industrial Property Organization, Membership and 
Advantages, http://www.aripo.wipo.net/membership.html (last visited Feb. 20, 
2006).  ARIPO is intended for the “study and promotion of and co-operation in 
industrial property matters.”  Agreement on the Creation of the African 
Regional Industrial Property Organization (ARIPO), Dec. 9, 1976, pmbl., 
available at http://www.wipo.int/clea/doc_new/en/zz/zz001en.html.  The 
objectives of ARIPO include the promotion of “the harmonization and 
development of the industrial property laws, and matters related thereto, 
appropriate to the needs of its members and of the region as a whole.”  Id. at 
art. III(a) (emphasis added). 
 97. See Protocol on Patents and Industrial Designs Within the Framework 
of the African Regional Industrial Property Organization (ARIPO), Dec. 10, 
1982, § 1, available at http://www.wipo.int/clea/docs_new/en/zz/zz004en.html. 
 98. Mushita & Thompson, supra note 13, at 77. 
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interests.99  The African Model Law seeks to implement the 
relevant provisions of the CBD100 and applies to biological 
resources in both in situ and ex situ conditions, derivatives of 
biological resources, community knowledge and technologies, 
local and indigenous communities, and plant breeders.101  
Access to such biological resources, knowledge, or technologies 
of local communities is granted by submitting an application 
for prior informed consent and a written permit.102  The 
application to the National Competent Authority103 must 
disclose the full details of the project for which the resource is 
required, including the purpose for which access to the resource 
is requested, the risks to biological diversity, and the proposed 
mechanisms and arrangements for benefit-sharing.104  The 
sharing of benefits based upon customary practices of local 
communities does not apply to “any person or persons not living 
in the traditional and customary way of life.”105 
Prior informed consent is also required from the concerned 
local community, including its female members.106  An access 
permit is granted through a signed written agreement among 
the three parties: the National Competent Authority, the 
community or communities concerned, and the applicant or 
collector.107  The contents of this tripartite agreement are 
regulated by Article 8 of the African Model Law.  Specifically, 
                                                          
 99. See African Model Legislation for the Protection of the Rights of Local 
Communities, Farmers and Breeders, and for the Regulation of Access to 
Biological Resources (2000), pmbl. [hereinafter African Model Law], available 
at http://www.grain.org/brl_files/oau-model-law-en.pdf. 
 100. See id. (stating that “there is a need to implement the relevant 
provisions of the Convention on Biological Diversity”). 
 101. Id. at art. 2(1).  The legislation, however, does not affect the 
“traditional systems of access, use or exchange of biological resources.”  Id. at 
art. 2(2)(i). 
 102. See id. at art. 3(1).  
 103. The “National Competent Authority is the entity authorized by the 
State to supervise and watch over the implementation of one or more of the 
components of the present law.”  Id. at art. 1. 
 104. See African Model Law, supra note 99, at art. 4.  A formula for 
“benefit-sharing” is provided for by Article 12 of the African Model Law.  In 
addition to a share of the actual earning derived from the biological resource 
or knowledge, a “permit fee” is also payable, in advance, based on “whether or 
not the collection is to be used for commercial purposes, and the number of 
samples, the area of collecting, the duration of collection and whether or not 
the collector is granted exclusive rights.”  Id. at art. 12(1). 
 105. Id. at art. 2(3). 
 106. See id. at art. 5(1). 
 107. See id. at art. 7(2). 
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the agreement requires the collector to contribute financially to 
the efforts of the state and communities concerned in the 
regeneration and conservation of the biological resource.  The 
collector may only apply for intellectual property protection of 
the biological resource, or parts or derivatives thereof, or for 
community knowledge or technology with the additional prior 
informed consent of the original providers.  Article 9 then goes 
on to provide that patents over life forms and biological 
processes will not be recognized and cannot be applied for, but 
does provide for plant breeders’ rights. 
The African Model Law recognizes and protects community 
rights,108 farmers’ rights,109 and plant breeders’ rights,110 and 
calls into question the suitability of intellectual property 
protection systems, particularly patent law, for developing 
countries where the main concern is often to secure food and to 
fight poverty.111 
D. THE OAU MODEL LAW ON SAFETY IN BIOTECHNOLOGY 
The OAU Model Law on Safety in Biotechnology, 
influenced by the Cartagena Protocol on Biosafety, seeks to 
harmonize existing legislation in the area of biosafety.  To that 
end, it provides a framework of biosafety regulations designed 
to protect Africa’s rich biodiversity, along with animal and 
human health, from the risks inherent in modern 
biotechnology.112 
The OAU Model Law on Safety in Biotechnology contains 
strict regulations concerning the “import, export, transit, 
contained use, release and placing on the market of any GMO 
[Genetically Modified Organism] and a product of a GMO, 
whether it is intended . . . for use as a pharmaceutical, for food, 
                                                          
 108. See id. at pt. IV.  
 109. See African Model Law, supra note 99, at pt. V. 
 110. See id. at pt. VI. 
 111. See Mushita & Thompson, supra note 13, at 79-80 (explaining that 
biodiversity, including indigenous plants, serves as a vital source of food and 
medicine for the poor, and that the need to protect related intellectual 
property rights is often, at most, a secondary priority).  See generally ULF 
ANDERFELT, INTERNATIONAL PATENT-LEGISLATION AND DEVELOPING 
COUNTRIES (1971). 
 112. MARIAM MAYET, WHY AFRICA SHOULD ADOPT THE OAU AFRICAN 
MODEL LAW ON SAFETY IN BIOTECHNOLOGY 1 (2003), available at 
http://www.biosafetyafrica.net/_DOCS/CommentBiosafetyModelLaw.pdf. 
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feed or processing.”113  Decisions in this regard must be based 
on the precautionary principle contained in the CBD.  The OAU 
Model Law also views “public participation and access to 
information as important and indispensable components of 
environmental governance.”114 
The regional arrangements, the two model laws drafted by 
the former OAU, align with the provisions of the CBD and 
associated law instruments rather than with the provisions of 
the TRIPS Agreement.  We shall now consider the route 
followed in domestic law in southern Africa, in particular South 
Africa. 
III. DOMESTIC LAW IN SOUTH AND SOUTHERN AFRICA 
Earlier forms of statutory protection for intellectual 
property in southern African domestic law merely aimed to 
extend the protection afforded to colonial proprietors of 
intellectual property.  For example, in Botswana the now-
repealed Patents and Designs Protection Act115 aimed to 
“provide for the protection in Botswana of inventions the 
subject of patents subsisting in the United Kingdom or in the 
Republic of South Africa.”116  Some African countries, which are 
now members of ARIPO, simply had no industrial property 
legislation, though non-statutory provisions were usually made 
for unlawful acts relating to intellectual property rights.117 
Although the idea of individual ownership of intellectual 
property is antithetical to traditional African society and 
customary practices, intellectual property laws nonetheless 
remained on the statute books after colonial rulers transferred 
power to their African successors.  African societies’ disfavor of 
private intellectual property rights is, however, illustrated by 
the activity, or rather inactivity, at industrial property offices 
in Africa generally.118  Nonetheless, Africa is duty-bound to 
                                                          
 113. Id. at 3. 
 114. Id. at 9.  
 115. Chapter 68:02, The Laws of Botswana, Revised Edition 1997.  The 
Patents and Designs Protection Act commenced on March 11, 1955 and has 
now been replaced by the Industrial Property Act 14 of 1996, available at 
http://www.tralac.org/pdf/Industrial_Property_Act_Botswana.pdf. 
 116. Patents and Designs Protection Act of 1955, pmbl. 
 117. T.D. BURRELL, BURRELL’S SOUTH AFRICAN PATENT AND DESIGN LAW § 
1.19.2 (3d ed. 1996) (stating that Ethiopia is an example of one such country). 
 118. Statistics from the U.N. Development Program and U.S. Patent Office 
reflect that in 2001, 2.5 technology patents per one million people in South 
Africa, where a fairly sophisticated intellectual property regime is in place, 
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implement and enforce the intellectual property rights 
prescribed by the TRIPS Agreement.119 
In South Africa, a plethora of policy documents and 
legislation relating to plant genetic resources for food and 
agriculture is in place that appears, on the surface at least, to 
comply with the major tenets of both the TRIPS and CBD 
agreements.  Of significance, and considered below, are the 
Patents Act 57 of 1978, the Plant Breeders’ Rights Act 15 of 
1976, the Genetically Modified Organisms Act of 1977, and the 
National Environmental Management: Biodiversity Act 10 of 
2004.  It is also useful to consider applicable provisions of the 
South African Constitution, as all laws in South Africa must be 
interpreted in a manner consistent with the Bill of Rights 
contained in the Constitution (and international law must be 
considered when interpreting the Bill of Rights).120 
A. CONSTITUTION OF THE REPUBLIC OF SOUTH AFRICA ACT 108 
OF 1996 (CONSTITUTION) 
The Bill of Rights121 in the Constitution of South Africa 
provides that everyone has a right of access to sufficient food 
and water,122 the right to an environment that is not harmful to 
health or well-being, and the right to environmental protection, 
for the benefit of present and future generations, through 
sustainable development and use of natural resources that also 
promotes economic and social development.123  The Bill of 
Rights also protects cultural associations.124 
                                                          
compared with twenty-five in Australia and 779 in South Korea.  See Alla 
Katsnelson, South Africa Fights Low Patent Rate, NATURE.COM, Oct. 14, 2004, 
http://www.nature.com/news/2004/041018/full/bioent834.html.  Intellectual 
property generally is not a priority in Africa.  In Angola, for example, in 
twenty-nine years only thirty trademarks were registered over Angolan 
industrial products.  See Press Release, Angola Press Agency, Angola 
Struggling to Make Inroads into Intellectual Property (Sept. 17, 2004), 
available at http://www.tralac.org/scripts/content.php?id=2919. 
 119. See TRIPS Agreement, supra note 14, at art. 41(1) (stating that 
members must provide enforcement mechanisms against infringements of the 
TRIPS Agreement).  Developing countries were given an extended period of 
time to amend domestic law to comply with the TRIPS Agreement.  See id. at 
art. 65(2). 
 120. See S. AFR. CONST. 1996 art. 39.  
 121. Id. at arts. 7-39. 
 122. See id. at art. 27(1)(b). 
 123. See id. at art. 24. 
 124. See id. at art. 31. 
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In addition, the Constitution provides that “no one may be 
deprived of property except in terms of law of general 
application, and no law may permit arbitrary deprivation of 
property.”125  Although property is specifically not limited to 
land,126 the scope of the property clause is otherwise unclear 
and could possibly include immaterial property rights.  
However, in In re Certification of the Constitution of the 
Republic of South Africa, 1996,127 the Constitutional Court 
held, in response to an objection raised regarding the failure to 
recognize a right to intellectual property, that it was not 
necessary to mention intellectual property separately as a 
universally accepted fundamental right in view of the fact that 
a right to intellectual property is “rarely recognised in regional 
conventions protecting human rights and in the constitutions of 
acknowledged democracies.”128  The objection was dismissed.129 
The Constitution goes on to provide that: 
Property may be expropriated only in terms of law of general 
application 
a.  for a public purpose or in the public interest; and 
b. subject to compensation, the amount of which and the time and  
manner of payment of which have either been agreed to by those 
affected or decided or approved by a court.130 
Public interest includes “reforms to bring about equitable 
access to all South Africa’s natural resources.”131  If, indeed, 
intellectual property is constitutionally protected, it is certainly 
possible to regulate “expropriation” for the public good.  It is 
argued that the principles of “deprivation” and “expropriation” 
apply to the vertical relationship between the state and 
property owners rather than between private individuals.132  
These relationships and the nuances relating to plant genetic 
resources have yet to be tested in terms of the Constitution. 
 
                                                          
 125.  Id. at art. 25(1).  The law of general application is sufficiently broad to 
refer to statutory law, common law, and customary law. 
 126. See S. AFR. CONST. 1996 art. 25(4)(b). 
 127. 1996 (4) SA 744 (S. Afr.). 
 128. Id. at 799 (internal citation omitted). 
 129. See id. at 800. 
 130. S. AFR. CONST. 1996 art. 25(2).  Expropriation is a form of deprivation 
for which compensation is received.  See P.J. BADENHORST, BILL OF RIGHTS 
COMPENDIUM § 3FB4 (1998). 
 131. S. AFR. CONST. 1996 art. 25(4)(a).  
 132. BADENHORST, supra note 130, § 3FB16. 
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B. PATENTS ACT 57 OF 1978 (PATENTS ACT) AND THE PATENTS 
AMENDMENT BILL OF 2005 
The Patents Act provides that a patent may be granted for 
any new invention involving an inventive step and which is 
capable of being used or applied in trade, industry, or 
agriculture.133  A patent shall not be granted, however, “for any 
variety of animal or plant or any essentially biological process 
for the production of animals or plants, not being a micro—
biological process or the product of such a process.”134  
Microbiological processes and the resultant products are 
patentable.135  While not protected by the Patents Act, certain 
plant varieties136 may be protected in terms of the Plant 
Breeders’ Rights Act 15 of 1976. 
For the purposes of establishing the scope of the 
“essentially biological process” exclusions, the Guidelines for 
Examiners in the European Patent Office are likely to be 
persuasive: 
The question whether a process is “essentially biological” is one of 
degree depending on the extent to which there is technical 
intervention by man in the process; if such intervention plays a 
significant part in determining or controlling the result it is desired to 
achieve, the process would not be excluded.  To take some examples, a 
method of crossing, inter-breeding, or selectively breeding, say, 
horses, involving merely selecting for breeding and bringing together 
those animals having certain characteristics would be essentially 
biological and therefore unpatentable.  On the other hand, a process 
of treating a plant or animal to improve its properties or yield . . . 
would not be essentially biological since although a biological process 
is involved, the essence of the invention is technical; the same could 
apply to a method of treating a plant characterized by the application 
of a growth-stimulating substance or radiation.  The treatment of soil 
by technical means to suppress or promote the growth of plants is also 
not excluded from patentability.137 
                                                          
 133. See Patents Act 57 of 1978 s. 25(1). 
 134. Id. at s. 25(4)(b). 
 135. See id.  Microbiology is defined as “the study of single-celled 
organisms too small to be observed with the naked eye.  Classically, this field 
has included the study of algae and protozoa.”  R. WILLIAMS & E. LANSFORD, 
ENCYCLOPEDIA OF BIOCHEMISTRY (1st ed. 1967), quoted in BURRELL, supra 
note 117, § 1.26.7 n.310. 
 136. The variety must be one of a plant species prescribed in the 
regulations to the Plant Breeders’ Rights Act, although it is possible to apply 
to have a plant added to the prescribed list.  See Kidd & Mayett, supra note 
18, at 239. 
 137. BURRELL, supra note 117, § 1.26.7 (emphasis added). 
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The provisions of the Patents Act, read together with the 
Plant Breeders’ Rights Act 15 of 1976, appear to comply with 
the relevant provisions of the TRIPS Agreement.  Insofar as 
compliance with the provisions of the CBD138 regarding 
indigenous knowledge, control, and access to plant genetic 
resources is concerned, it is necessary to consider the proposed 
amendments to the Patents Act contained in the Patents 
Amendment Bill, the object of which is to “empower the 
registrar of patents to refuse or revoke a patent which is based 
on biological material, [and to] refuse, revoke or invalidate a 
patent which is based on prior knowledge associated with such 
materials.”139  Once amended, the Patents Act will “require an 
applicant for a patent to furnish information relating to any 
role played by an indigenous biological resource, a genetic 
resource or traditional knowledge or use in an invention.”140  
More specifically, the Bill amends the Act by inserting the 
following provisions: 
(3A) Every applicant who lodges an application for a patent . . . shall . 
. . lodge with the registrar a statement in the prescribed manner 
stating whether or not the invention for which protection is claimed is 
based on or derived from an indigenous biological resource, genetic 
resource, or traditional knowledge or use. 
(3B) The registrar shall call upon the applicant to furnish proof in the 
prescribed manner as to his or her title or authority to make use of 
the indigenous biological resource, genetic resource, or of the 
traditional knowledge or use if an applicant lodges a statement that 
acknowledges that the invention for which protection is claimed is 
based on or derived from an indigenous biological resource, genetic 
resource, or traditional knowledge or use.141 
These amendments bring the Patents Act in line with the 
National Environmental Management Biodiversity Act, which 
incorporates the provisions of the CBD and the Bonn 
Guidelines regarding benefit-sharing schemes in relation to 
genetic resources and traditional knowledge used in patent 
inventions.142 
                                                          
 138. See also National Environmental Management: Biodiversity Act 10 of 
2004. 
 139. Memorandum on the Objects of the Patents Amendment Bill s. 4.1(a), 
Patents Amendment Bill, 2005, Bill 17B-05 (GA). 
 140. Patents Amendment Bill, 2005, Bill 17B-05 pmbl. (GA). 
 141. Id. at s. 2. 
 142. See generally National Environmental Management: Biodiversity Act 
10 of 2004 s. 83. 
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C. PLANT BREEDERS’ RIGHTS ACT 15 OF 1976 (PLANT BREEDERS’ 
ACT) 
The Plant Breeders’ Act provides “for a system whereunder 
plant breeders’ rights relating to varieties of certain kinds of 
plants may be granted and registered”143 and essentially 
corresponds with the model offered by the International Union 
for the Protection of New Varieties of Plants (UPOV), hence 
meeting South Africa’s obligations arising out of Article 27(3)(b) 
of the TRIPS Agreement. 
The Plant Breeders’ Act does not require the prior 
informed consent of affected communities and does not provide 
for material transfer or benefit-sharing agreements.144  A plant 
breeder’s right is granted for twenty-five years with respect to 
vines and trees and twenty years for everything else.145  During 
the currency of the protection, a license is required for: 
(a) production or reproduction (multiplication); 
(b) conditioning for the purposes of propagation; 
(c) sale or any other form of marketing; 
(d) exporting; 
(e) importing; 
(f) stocking for any of the purposes referred to in paragraphs (a) to (e), 
  of – 
  (i) propagating material of the relevant variety; or 
     (ii) harvested material, including plants, which was obtained       
through the unauthorized use of propagating material of the relevant 
variety.146 
However, where a person has procured propagating 
material of a protected variety in a legitimate matter, it shall 
not be an infringement to resell the propagating material or 
any plant or product derived from the propagating material, or 
to use or multiply the propagating material in the development 
of a different variety.147  Neither is it an infringement to use 
the propagating material for bona fide research or private or 
non-commercial purposes,148 nor where the person who 
                                                          
 143. Plant Breeders’ Act 15 of 1976 pmbl. 
 144. See generally Plant Breeders’ Act 15 of 1976. 
 145. Id. at s. 21. 
 146. Id. at s. 23(1). 
 147. See id. at s. 23(6)(a)-(c). 
 148. See id. at  s. 23(6)(d)-(e).  
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acquires the material is a farmer who uses harvested material 
obtained on land occupied by him from the propagating 
material for purposes of propagation, provided that the 
harvested material shall not be used for propagation by any 
person other than that farmer.149  Sections 26 and 27 of the 
Plant Breeders’ Act provide mechanisms and principles for the 
application for and granting of a compulsory license to deal 
with a protected plant variety where the holder of a plant 
breeder’s right has unreasonably refused to grant a license or 
has imposed unreasonable conditions. 
D. GENETICALLY MODIFIED ORGANISMS ACT 15 OF 1997 (GMO 
ACT) 
The GMO Act is the key biosafety law in South Africa, and 
on its face, is not concerned about indigenous knowledge and 
control and access to plant genetic resources.  Instead, the 
GMO Act seeks: 
To provide for measures to promote the responsible development, 
production, use and application of genetically modified organisms; to 
ensure that all activities involving the use of genetically modified 
organisms (including importation, production, release and 
distribution) shall be carried out in such a way as to limit possible 
harmful consequences to the environment; to give attention to the 
prevention of accidents and the effective management of waste; to 
establish common measures for the evaluation and reduction of the 
potential risks arising out of activities involving the use of genetically 
modified organisms; to lay down the necessary requirements and 
criteria for risk assessments; to establish a council for genetically 
modified organisms; to ensure that genetically modified organisms 
are appropriate and do not present a hazard to the environment; and 
to establish appropriate procedures for the notification of specific 
activities involving the use of genetically modified organisms; and to 
provide for matters connected therewith.150 
What is of concern, and ultimately impacts control and 
access to plant genetic resources, is the lack of public 
participation and lack of access to information provided for by 
the GMO Act.151  This is exacerbated by the lack of regulations 
with respect to labeling of genetically modified products.152 
                                                          
 149. See id. at s. 23(6)(f). 
 150. Genetically Modified Organisms Act 15 of 1997 pmbl. 
 151. See MARIAM MAYET, CRITICAL ANALYSIS OF PERTINENT LEGISLATION 
REGULATING GENETIC MODIFICATION IN FOOD AND AGRICULTURE IN SOUTH 
AFRICA 20-39 (2001).  
 152. Labeling of foodstuffs is currently regulated by the Foodstuffs, 
Cosmetics and Disinfectants Act 54 of 1972 s. 5. 
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Numerous decisions taken under the GMO Act have been 
subjected to appeal,153 and the lack of access to information 
has, on at least one occasion, resulted in litigation in the High 
Court of South Africa.  In Trustees for the Time Being of the 
Biowatch Trust v. Registrar: Genetic Resources,154 Biowatch 
South Africa, a small environmental organization, approached 
the High Court to compel the government to disclose 
information about genetically modified crops entering South 
Africa and being grown in South Africa.155  Although Biowatch 
was largely successful in the application, a costs order was 
granted against Biowatch in favor of Monsanto,156 an action 
that could potentially cripple the organization, notwithstanding 
the fact that it had been Monsanto’s choice to be joined in the 
litigation. 
Amendments to the GMO Act have been proposed to 
incorporate provisions of the Cartagena Protocol on 
Biosafety.157  The amendments have, however, been criticized 
for a failure, again, to allow for adequate public participation 
and information sharing, and also for failing to adopt a policy 
in line with the precautionary approach.158 
E. NATIONAL ENVIRONMENTAL MANAGEMENT: BIODIVERSITY 
ACT 10 OF 2004 (BIODIVERSITY ACT) 
One of the objectives of the Biodiversity Act is “to give 
effect to ratified international agreements relating to 
                                                          
 153. For example, in 2004’s Trustees for the Time Being of the Biowatch 
Trust v. Syngenta Seed Co. (PTY), Biowatch South Africa lodged an 
unsuccessful appeal with the Appeal Board, in terms of the GMO Act, against 
a decision of the Executive Council for GMOs granting authorization to 
Syngenta Seed to import, release, and conduct field trials pertaining to Bt 11 
maize in South Africa under particular conditions.  See Melanie Gosling, 
Biowatch Loses Appeal Against GM Maize Company, MERCURY, Dec. 27, 2004, 
available at 
http://www.themercury.co.za/index.php?fSectionId=283&fArticleId=2355874. 
 154. No. 23005/2002 (High Ct. S. Afr. (Transvaal Provincial Div.) Feb. 23, 
2005). 
 155. See id. at 10-20. 
 156. See id. at 61-65. 
 157. Genetically Modified Organisms Amendment Bill, 2004, Bill 26848 
pmbl. (GA). 
 158. See JERRY BOLTINA, PORTFOLIO COMM. ON AGRIC. AND LAND AFFAIRS, 
SUBMISSION ON GENETICALLY MODIFIED ORGANISMS AMENDMENT BILL 1-3 
(2005). 
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biodiversity which are binding on the Republic.”159  
Accordingly, the Biodiversity Act aims to provide for the 
“sustainable use of indigenous biological resources; [and] the 
fair and equitable sharing of benefits arising from 
bioprospecting involving indigenous biological resources.”160  
From the subsequent wording of the Biodiversity Act it would 
appear that the “international agreements” referred to include 
both the CBD and the ITPGR. 
Chapter 6 of the Biodiversity Act deals with 
bioprospecting, access, and benefit-sharing related to 
indigenous biological resources.161  Specifically excluded from 
the operation of Chapter 6 are: (1) genetic material of human 
origin, (2) any exotic animals, plants, or other organisms,162 
and (3) indigenous biological resources listed in terms of the 
ITPGR.163 
Persons who wish to “engage in bioprospecting involving 
any indigenous biological resources” or “export from the 
Republic any indigenous biological resources for the purpose of 
bioprospecting or any other kind of research” are required to 
obtain a permit.164  The authority that issues the permit is 
required to protect any interests that the following 
stakeholders may have in the bioprospecting project: 
                                                          
 159. See National Environmental Management: Biodiversity Act 10 of 2004 
s. 2(b). 
 160. Id. at pmbl.  Bioprospecting involves “any research on, or development 
or application of, indigenous biological resources for commercial or industrial 
exploitation, and includes – (a) the systematic search, collection or gathering 
of such resources.”  Id. at s. 1. 
 161. “Indigenous biological resources” is defined to include “(i) any living or 
dead animal, plant or other organism of an indigenous species; (ii) any 
derivative of such animal, plant or other organism; or (iii) any genetic material 
of such animal, plant or other organism.”  Id. at s. 1.  When used in relation to 
bioprospecting, indigenous biological resources include the above “whether 
gathered from the wild or accessed from any other source, including any 
animals, plants or other organisms of an indigenous species cultivated, bred or 
kept in captivity or cultivated or altered in any way by means of 
biotechnology; and any cultivar, variety, strain, derivative, hybrid or fertile 
version [derived therefrom].”  Id. at s. 80(2)(a)(i-ii).  When used in relation to 
bioprospecting, indigenous biological resources also include “any exotic 
animals, plants or other organisms, whether gathered from the wild or 
accessed from any other source which, through the use of biotechnology, have 
been altered with any genetic material or chemical compound found in any 
indigenous species or any [other indigenous resources].”  Id. at s. 80(2)(a)(iii). 
 162. Except those referred to in section 80(2)(a)(iii) of the National 
Environmental Management: Biodiversity Act 10 of 2004.  
 163. See id. at s. 80(2)(b). 
 164. Id. at s. 81(1). 
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(a)      A person, including any organ of state or community, providing 
or giving access to the indigenous biological resources to which the 
application relates; and 
(b)     an indigenous community —— 
     (i)     whose traditional uses of the indigenous biological resources 
to which the application relates have initiated or will contribute to or 
form part of the proposed bioprospecting; or 
     (ii)  whose knowledge of or discoveries about the indigenous 
biological resources to which the application relates are to be used for 
the proposed bioprospecting.165 
In the event that a stakeholder has an interest, a permit 
may be issued only if the applicant has disclosed all material 
information to the stakeholder and thereafter obtained the 
prior consent of the stakeholder.166  In addition, the applicant 
and the stakeholder must enter into a material transfer 
agreement regulating access to the resources, and a benefit-
sharing agreement that the stakeholder share in future 
benefits derived from the bioprospecting.167  The Minister 
responsible for national environmental management must 
approve the material transfer and benefit-sharing 
agreements.168  The principles for benefit-sharing and material 
transfer agreements are set out in the Biodiversity Act.169 
One example of a benefit-sharing model in South Africa is 
the agreement—entered into before the Biodiversity Act 
became operative—between the San communities and the 
Council for Scientific and Industrial Research (CSIR) with 
respect to the indigenous Hoodia cactus that has chemical 
properties useful for fighting obesity.170  For centuries, 
indigenous communities have chewed on the Hoodia leaf as an 
appetite suppressant.171  Since 1986, the CSIR has filed 
worldwide patents with respect to a method of obesity control 
that uses the chemical composition of the Hoodia plant and has 
subsequently negotiated a benefit-sharing agreement with the 
owners of the traditional knowledge.  This agreement 
stipulates that the CSIR will pay the San eight percent of the 
                                                          
 165. Id. at s. 82(1)(a-b). 
 166. See id. at s. 82. 
 167. See id. at s. 82(2)(b). 
 168. See National Environmental Management: Biodiversity Act of 2004 s. 
82(2)(c). 
 169. See id. at ss. 83-84. 
 170. See Terblanche, supra note 18, at 61-62. 
 171. See id. at 61. 
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payments it receives from its licensee(s)172 and six percent of all 
royalties the CSIR receives once the drug is commercially 
available.173 
South Africa was the first country on the African continent 
to grow genetically modified crops and accordingly, fairly 
sophisticated legislation, such as that discussed above, has 
resulted.  The legislation however has proved to be ineffective 
in protecting vulnerable communities and the environment.  
This is illustrated in the case of genetically modified cotton 
grown in South Africa.174   
IV. A CASE IN POINT: GENETICALLY MODIFIED COTTON 
IN SOUTH AFRICA 
Cotton crops can withstand harsh climates, making cotton 
a useful cash crop for farmers in Africa.  After the United 
States and Uzbekistan, Africa is the third largest cotton export 
region in the world,175 and is therefore a target for genetically 
modified cotton plants.176  South Africa is currently the only 
African country to allow the commercial planting of genetically 
modified cotton,177 although field trials are being conducted in 
other parts of Africa, including Egypt, Mali, and Burkina 
Faso.178 
It must be asked, who are the true beneficiaries of 
genetically modified cotton crops in South Africa?  Much of the 
uptake of genetically modified crops in South Africa is in 
commercial agriculture, although small-holder farmers are 
                                                          
 172. The UK-based botanical pharmaceutical company Phytopharm is one 
such licensee.  See id. 
 173. See id. at 62. 
 174. See ELFRIEDA PSCHORN-STRAUSS, BIOWATCH SOUTH AFRICA, BT 
COTTON AND SMALL-SCALE FARMERS IN MAKHATHINI – A STORY OF DEBT, 
DEPENDENCY, AND DICEY ECONOMICS, available at 
http://www.grain.org/research/btcotton.cfm?id=100 (last visited Feb. 25, 2006).  
India and China farmers have followed suit.  See id. 
 175. See GREENBERG, supra note 31, at 4. 
 176. The purported benefit of Bt cotton is that the need for insecticides 
should decrease because the insecticide is built into the genetic structure of 
the plant.  See id.  This should result in reduced cost to the farmer and 
reduced environmental damage. 
 177. See PSCHORN-STRAUSS, supra note 174.  It is estimated that eighty 
percent of the cotton grown in South Africa is genetically engineered.   
ELFRIEDA PSCHORN-STRAUSS, BIOWATCH SOUTH AFRICA, BRIEFING NO. 2: 
WHAT IS SOUTH AFRICA DOING ABOUT GENETICALLY ENGINEERED CROPS? 1 
(2004), http://www.biowatch.org.za/pubs/briefings/2004/briefing02.pdf. 
 178. See GREENBERG, supra note 31, at 20-21. 
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being encouraged to plant genetically modified crops.  This 
encouragement came after a “successful” pilot project in 
Makhathini that has been touted by multinational 
agribusinesses throughout Africa and beyond.179 
Although it is assumed that biotechnology in agriculture 
would be introduced predominantly through public institutions 
and processes,180 this is not necessarily so.  In 1997, the Bt 
cotton plant, sold as Bollgard®, was introduced to the 
Makhathini Flats in northern Kwa-Zulu Natal by Monsanto 
and Delta Pine, supported by public institutions such as the 
Department of Agriculture, and supported financially by 
Vunisa Cotton, a private company, and the Land Bank, a 
government bank.181  It would appear from the report by 
Elfrieda Pschorn-Strauss that the biosafety trials, which should 
have been conducted two or three years before the release of 
the plant to farmers, were conducted almost simultaneously 
with its release.182  Nevertheless, the Makhathini project was 
hailed a success183 and was used not only as a means to put 
pressure on other African countries to adopt genetically 
modified crops,184 but also as a moral justification for United 
States action against the European Union. The argument is 
that Europe’s cautious approach toward genetically modified 
food has a detrimental effect on Africa’s potential to fight 
poverty and food insecurity.185  The “success” however was 
                                                          
 179. Biowatch reports that ”[i]n the 2001/2002 season 300 large-scale 
farmers produced 95% of the crop, while 3000 small-scale farmers on the 
Makhathini Flats in Northern KwaZulu Natal and in the south-eastern part of 
Mpumalanga produced the remaining 5%.”  ELFRIEDA PSCHORN-STRAUSS & 
CRISTINE JARDINE, BIOWATCH SOUTH AFRICA, BRIEFING NO. 3: GENETICALLY 
ENGINEERED COTTON: HIGH RISKS, LOW RETURNS 1 (2004), 
http://www.biowatch.org.za/pubs/briefings/2004/briefing03.pdf. 
 180. See Taylor & Cayford, supra note 3, at 335. 
 181. PSCHORN-STRAUSS & JARDINE, supra note 179, at 3.  Vunisa Cotton, 
established by Clark Cotton, serves as an agent for seed and agrochemical 
companies in the area and also buys back cotton from the farmers after 
harvest.  See id. 
 182. See PSCHORN-STRAUSS, supra note 174. 
 183. Reports by the genetic modification industry indicate that the cotton 
yields of the small-holder farmers increased dramatically by up to 220%.  See 
PSCHORN-STRAUSS, supra note 174.  What the reports fail to indicate, among 
much else, is the artificial level of support and the package of inputs that 
accompanied the seeds.  See id.   
 184. Pressured countries include Uganda, Zambia, and Zimbabwe.  See id. 
 185. See id.  A Makhathini farmer has even been used in argument by the 
United States in its action at the WTO against the European Union’s labeling 
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short-lived, as subsequent floods and droughts left farmers 
with staggering debt.186  By all accounts the Makhathini project 
is now in tatters. 
Farmers were encouraged to purchase Monsanto’s 
Bollgard® seed on the basis that the crops would increase the 
farmers’ yields and would require reduced insecticide 
spraying.187  Additional inputs into the Makhathini project 
included a donation from Monsanto of $10,000 to the Ubombo 
Farmers Association for the purchase of farming equipment in 
2001.188 
Farmers who purchased the expensive seed were required 
to sign a Monsanto Technology Agreement, in terms of which 
they undertook to: 
? Use the seed for planting a commercial crop for only 
one season; 
? Plant a refuge as part of the insect resistance 
management strategy; 
? Not supply any seed containing Bollgard® to any 
third party; 
? Not use or provide seed containing Bollgard® to 
anyone for crop breeding, research, or seed 
production; 
? Not ratoon any Bollgard® cotton; 
? Allow Monsanto agents to inspect the growers’ 
fields to ensure that the correct refuge areas have 
been planted.189 
Pschorn-Strauss ascertained, during a 2001 survey of 
twelve farmers who planted Bollgard®, that they did not 
understand the contracts they had signed.190  It is even 
reported that “farmers understand their contracts to mean that 
in the case of a crop failure, the seed will be replaced.”191 
Only one of the twelve farmers told Pschorn-Strauss that 
he had been fully apprised of the terms of the contract; five of 
the twelve were aware of the need to plant refuges and only 
three had done so.192  One of the concerns is that responsibility 
                                                          
restrictions for genetically modified products.  See id. 
 186. PSCHORN-STRAUSS & JARDINE, supra note 179, at 3. 
 187. See PSCHORN-STRAUSS, supra note 174. 
 188. See id. 
 189. Id. 
 190. See id. 
 191. See id. 
 192. See id.  Moreover: 
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for monitoring and risk assessment is not adequately addressed 
by the government in South Africa.193  The current legislative 
framework would probably allow seed companies to escape 
liability for damage. 
In addition to the environmental concerns,194 the 
Makhathini project raises numerous socio-economic 
concerns.195  At the center of the socio-economic concerns is the 
cost of accessing genetically modified crops.  The poverty gap 
between farmers who are able to afford the technology and 
those who are not196 is likely to widen, and the farmers who are 
able to access genetically modified crops could become trapped 
in a debt-cycle that is far worse than the debt-cycles already 
experienced by farmers growing non-genetically modified 
crops.197 
Access to land is an additional socio-economic and political 
concern in post-apartheid South Africa.  Currently much of the 
area under discussion is predominantly owned by the state and 
is held in trust by the Minister of Land Affairs until such time 
as it is redistributed to the inhabitants of the area.  One of the 
issues is whether the land should be redistributed as freehold 
land or whether it should become communal land.  The 
outcome could have major implications for current inhabitants.  
Pending the outcome of these deliberations, inhabitants are 
                                                          
The industry has recognised the real possibility of resistance 
developing and has made it a contractual requirement that users of 
Bt crops plant refuges of non-GE varieties to ensure that a sub-
population of insects is not exposed to Bt toxin.  This sub-population 
will not develop any resistance and will pass on the non-resistant 
gene, diluting the resistant genes coming from insects that have been 
exposed to and survived Bt toxin. 
PSCHORN-STRAUSS & JARDINE, supra note 179, at 4.   
 193. PSCHORN-STRAUSS & JARDINE, supra note 179, at 3. 
 194. There is growing evidence that the benefits, or effectiveness, of 
genetically engineered cotton crops decreases over time.  In Australia, for 
example, one study reports that the pesticide benefits of Monsanto’s 
genetically engineered Ingard cotton varieties steadily declined from one 
season to the next: “Average use of insecticide . . . was 52% less in 1996/1997 
(season of Ingard introduction), 44% less in 1997/1998, and only 38% less in 
1998/1999.”  Id. 
 195. See PSCHORN-STRAUSS, supra note 174. 
 196. Small loans in South Africa are inordinately expensive.  The 
microlending industry in South Africa does not adequately address the needs 
of small businesses and enterprises and is currently under review.  It is likely 
that a new National Credit Bill will replace the existing legal infrastructure.  
 197. See PSCHORN-STRAUSS, supra note 174. 
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reluctant to commit to the land on a long-term basis. 
Since the introduction of genetically engineered cotton, it is 
reported that the number of cotton varieties available to 
farmers has decreased (and available varieties are 
predominately genetically engineered198), production has fallen, 
the cost has increased, many jobs have been lost, and spinners 
have expressed dissatisfaction with the quality of cotton now 
being produced.199 
CONCLUSION 
Attempts to control and regulate access to genetic 
resources must be seen in light of the history and context of 
agriculture in Africa: “Genetic resources at the local, national, 
and international levels, play a critical role in the lives of all 
Africans.  The most obvious aspect of this is food.”200 
Africa should be cautious in its approach to modern 
biotechnology applications in agriculture for it may not hold the 
solutions that Africa seeks.  Rather, an introspective approach 
to agriculture is necessary.  Namely, agriculture in Africa 
needs to be considered in the broader historical, social, 
economic, and political context of the continent.  While it might 
be difficult to influence global policy to prevent the anomalies, 
such as the misappropriation of indigenous knowledge, 
occurring in developed countries, at least domestic law in 
Africa can remain true to the interests of its communities and 
the principles of international environmental law.  To some 
extent the law in South Africa mirrors the principles of the 
CBD, while still implementing the provisions of TRIPS.  The 
law in South Africa, however, has major pitfalls, insofar as 
public participation, awareness (for example, labeling), and the 
best interest of its people are concerned. 
It should not be forgotten that it is the genetic resources of 
indigenous plants themselves, and not access to global markets, 
which can provide Africa with food security and traditional 
medicine.201  Domestic legislative measures with respect to 
                                                          
 198. For 2002, it is indicated that genetically engineered seed accounted for 
seventy-five percent of the market: Bt cotton (thirty-five percent), RR cotton 
(ten percent), and stacked varieties (thirty percent).  See PSCHORN-STRAUSS & 
JARDINE, supra note 179, at 3.     
 199. See id. 
 200. See The Significance of Genetic Resources in Africa, in AFRICAN 
PERSPECTIVES ON GENETIC RESOURCES, supra note 18, at 9, 23. 
 201. Mushita & Thompson, supra note 13, at 80. 
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indigenous knowledge and control and access to plant genetic 
resources must respect this fact.  In short, the provisions of the 
CBD and the ITPGR should shield Africa against undue 
pressure for domestic legislation to comply with the letter of 
the law contained in the TRIPS Agreement. 
 
 
